alexa Radioimmunotherapy | List of High Impact Articles | PPts | Journals | Videos
Journal of Nuclear Medicine & Radiation Therapy

ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy


Search results for

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Radioimmunotherapy (RIT) is a combination of radiation therapy and immunotherapy where a laboratory-produced molecule called a monoclonal antibody is introduced on to surface of cell to recognize and bind to cell. Monoclonal antibodies mimic the antibodies naturally produced by the body’s immune system that attack invading foreign substances. The two agents mostly used are Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) and Iodine-131 Tositumomab (Bexxar®) in radioimmunotherapy treatment.

Radioimmunotherapy (RIT) has become an essential advanced treatment for relapsed and/or refractory indolent NHL, with many studies reporting survival and quality-of-life benefits. As it is known that, Radioimmunotherapy (RIT) is a combination of radiation therapy and immunotherapy, where as a monoclonal antibody is paired with a radioactive material, or radiotracer. Radioimmunotherapy is performed by a radiologist, nuclear medicine physician or radiation oncologist. Radioimmunotherapy could result in reducing blood counts.

Related Journals of Radioimmunotherapy

Radiation Research.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version